Skip to content
10-Q

Quarterly Report

Elicio Therapeutics, Inc. ELTX

0001601485-25-000124

← back to feed
Filed
Nov 13, 2025 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2025 · Nov 10, 2025 17.49M sh
Shares Diluted Q3 2025 · Sep 30, 2025 16.69M sh
Shares Diluted Q3 2025 · Sep 30, 2025 15.25M sh
Shares Diluted Q3 2025 · Sep 30, 2024 13.58M sh
Shares Diluted Q3 2025 · Sep 30, 2024 11.72M sh
Capex Q3 2025 · Sep 30, 2025 $0
Capex Q3 2025 · Sep 30, 2024 $42K
Operating Cash Flow Q3 2025 · Sep 30, 2025 −$30.16M
Operating Cash Flow Q3 2025 · Sep 30, 2024 −$28.32M
Long Term Debt Q3 2025 · Sep 30, 2025 $9.72M
Long Term Debt Q3 2025 · Dec 31, 2024 $20.03M
Cash And Equivalents Q3 2025 · Sep 30, 2025 $20.61M
Cash And Equivalents Q3 2025 · Dec 31, 2024 $17.62M
Cash And Equivalents Q3 2025 · Sep 30, 2024 $26.02M
Stockholders Equity Q3 2025 · Sep 30, 2025 $3.82M
Stockholders Equity Q3 2025 · Jun 30, 2025 $1.83M
Stockholders Equity Q3 2025 · Mar 31, 2025 $8.9M
Stockholders Equity Q3 2025 · Dec 31, 2024 −$11.31M
Stockholders Equity Q3 2025 · Sep 30, 2024 −$18.99M
Stockholders Equity Q3 2025 · Jun 30, 2024 −$1.65M
Stockholders Equity Q3 2025 · Mar 31, 2024 $4.87M
Stockholders Equity Q3 2025 · Dec 31, 2023 $11.37M
Current Liabilities Q3 2025 · Sep 30, 2025 $6.52M
Current Liabilities Q3 2025 · Dec 31, 2024 $11.52M
Total Liabilities Q3 2025 · Sep 30, 2025 $24.47M
Total Liabilities Q3 2025 · Dec 31, 2024 $39.49M
Current Assets Q3 2025 · Sep 30, 2025 $21.47M
Current Assets Q3 2025 · Dec 31, 2024 $20.69M
Total Assets Q3 2025 · Sep 30, 2025 $28.28M
Total Assets Q3 2025 · Dec 31, 2024 $28.18M
Eps Diluted Q3 2025 · Sep 30, 2025 −$0.60
Eps Diluted Q3 2025 · Sep 30, 2025 −$2.09
Eps Diluted Q3 2025 · Sep 30, 2024 −$1.39
Eps Diluted Q3 2025 · Sep 30, 2024 −$3.23
Eps Basic Q3 2025 · Sep 30, 2025 −$0.60
Eps Basic Q3 2025 · Sep 30, 2025 −$2.09
Eps Basic Q3 2025 · Sep 30, 2024 −$1.39
Eps Basic Q3 2025 · Sep 30, 2024 −$3.23
Sga Expense Q3 2025 · Sep 30, 2025 $3.01M
Sga Expense Q3 2025 · Sep 30, 2025 $9.05M
Sga Expense Q3 2025 · Sep 30, 2024 $3.14M
Sga Expense Q3 2025 · Sep 30, 2024 $8.56M
Rd Expense Q3 2025 · Sep 30, 2025 $5.04M
Rd Expense Q3 2025 · Sep 30, 2025 $19.82M
Rd Expense Q3 2025 · Sep 30, 2024 $7.21M
Rd Expense Q3 2025 · Sep 30, 2024 $22.95M
Net Income Q3 2025 · Sep 30, 2025 −$10.08M
Net Income Q3 2025 · Sep 30, 2025 −$31.85M
Net Income Q3 2025 · Jun 30, 2025 −$10.56M
Net Income Q3 2025 · Mar 31, 2025 −$11.21M
Net Income Q3 2025 · Sep 30, 2024 −$18.84M
Net Income Q3 2025 · Sep 30, 2024 −$37.89M
Net Income Q3 2025 · Jun 30, 2024 −$7.23M
Net Income Q3 2025 · Mar 31, 2024 −$11.83M
Operating Income Q3 2025 · Sep 30, 2025 −$8.05M
Operating Income Q3 2025 · Sep 30, 2025 −$28.87M
Operating Income Q3 2025 · Sep 30, 2024 −$10.34M
Operating Income Q3 2025 · Sep 30, 2024 −$31.51M